Japan Archives

News and Trends 19 Sep 2022

Taiwan-based Anyong Biotechnology first to employ seafood stem-cell freezing

Anyong Biotechnology is the first company in its region to use the most advanced freezing technology in Asia, it was announced today (September 19). The aquatic food processing company based in Taiwan has employed Cells Alive System (CAS) technology from Japan. Originally a medical-grade technology for freezing stem cells, Anyong says CAS is highly praised […]

September 19, 2022 - 3 minutesmins - By Liza Laws

News and Trends 12 Sep 2022

Liquid-interface assisted SERS could lead to earlier detection of Alzheimer’s

In a new publication in Opto-Electronic Advances, Japanese researchers discussed label-free trace detection of bio-molecules by liquid-interface assisted surface-enhanced Raman scattering (SERS) using a microfluidic chip. SERS has attracted attention in biotechnology. This is due to its high sensitivity to localized surface plasmon resonance of nanostructured metals. Trace detection of bio-molecules with large molecular weight […]

September 12, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 8 Sep 2022

OncoBone signs deals with three partners to work on bone metastases

OncoBone Ventures has signed cooperation framework agreements with three partners. The company is a U.K. start up biotech looking to develop novel therapies for cancer patients with currently incurable bone metastases. The partners are: Okayama University in Japan, the University of Bradford in the U.K., and The Development Center for Biotechnology in Taiwan. The agreements […]

September 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 31 Aug 2022

Researchers try to bridge gap in link for patients with salmonella infection and clogged arteries

Researchers from Taiwan have discovered that patients with non-typhoidal salmonella (NTS) have higher aortic calcification and elevated plasma levels, which are an inflammatory biomarker. They say their findings suggest the need for early diagnosis of the condition in patients with atherosclerosis risk factors. NTS is a foodborne bacterium causing gastrointestinal infections and can cause life-threatening […]

August 31, 2022 - 4 minutesmins - By Liza Laws

News and Trends 30 Aug 2022

Scientists unravel mystery behind neurodegenerative disease protein

Scientists have unraveled the mystery behind the mechanism behind a type of protein that leads to a progressive nervous system disease. In a study, recently published in the journal Physical Chemistry Chemical Physics, the researchers say that the RNA-binding ‘fused in sarcoma’ (FUS) protein transitions between liquid and solid phases inside cells. The scientists from […]

August 30, 2022 - 4 minutesmins - By Liza Laws

News and Trends 24 Aug 2022

Potential new treatment for angioimmunoblastic T-cell lymphoma?

A type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from which the T cells in the blood develop. However, the underlying mechanism by which AITL develops was unknown. Now, a team from the University of Tsukuba in Japan have shown that B […]

August 24, 2022 - 3 minutesmins - By Jim Cornall

Five sustainable tech companies in JapanAnastasiia Slynko

Best in Biotech 23 Aug 2022

Five industrial biotech companies making Japan more sustainable

Japan has big plans to lead the world’s push to become more sustainable. Here are five local sustainable tech companies that could help it meet this mission. Japan is best known for its well-developed technology and manufacturing firms. The nation also hosts a thriving biotechnology sector, with players across sectors including healthcare and industrial biotechnology. […]

August 23, 2022 - 6 minutesmins - By Jonathan Smith

Kintor Pharmaceutical drug gets positive results for breast cancer

News and Trends 19 Aug 2022

Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy

All of Everest Medicine’s development and commercialization rights for a breast cancer drug called Trodelvy have been transferred to American biopharma Gilead Sciences Inc. The transfer of the antibody drug, sacituzumab govitecan treatment, will apply to Greater China, South Korea, Singapore, Indonesia, Philippines, Vietnam, Thailand, Malaysia and Mongolia. In China mainland and Singapore, Trodelvy is […]

August 19, 2022 - 3 minutesmins - By Liza Laws

News and Trends 17 Aug 2022

New partnership delivers clinically proven products and manufacturing processes for advanced therapies

AGC Biologics has announced its partnership with supplier of human mesenchymal stem/stromal cells (hMSCs), RoosterBio Inc. The partnership, the companies say creates an end-to-end solution for the development and production of hMSCs and exosome therapeutics using RoosterBio’s well-established cell and media products and process development services together with AGC’s cell and gene therapy manufacturing capabilities. […]

August 17, 2022 - 3 minutesmins - By Liza Laws

News and Trends 8 Aug 2022

HUTCHMED drug in colorectal cancer trial meets primary endpoint

A trial to look at the use of a drug targeting refractory metastatic colorectal cancer (CRC) has met its primary endpoint of overall survival (OS) in patients with the disease. China’s HUTCHMED Limited announced today (August 8) that the phase 3 FRESCO-2 trial investigating the use of fruquintinib had met all secondary endpoints too. The […]

August 8, 2022 - 3 minutesmins - By Liza Laws

News and Trends 5 Aug 2022

Neurocrine to conduct placebo-controlled study to investigate potential new treatment for schizophrenia

A phase 2 clinical trial for the treatment of schizophrenia has been accepted by the US Food and Drug Administration (FDA) and a study can now go ahead. Neurocrine Biosciences received the news and informed its partner Sosei Group Corporation. The approval of the study of NBI-1117568 has triggered a $30 million payment to Sosei. […]

August 5, 2022 - 3 minutesmins - By Liza Laws

News and Trends 3 Aug 2022

Deciphering the molecular mechanisms of severe COVID-19

Researchers from Fujita Health University School of Medicine in Japan have been investigating COVID-19 to lead to therapeutic options against the severe form of the condition. Levels of proinflammatory cytokines are dramatically elevated in severe COVID-19 patients, the molecular mechanisms of which remain unclear. In a recent article in mBio, the researchers elucidated the role […]

August 3, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Japan

Taiwan-based Anyong Biotechnology first to employ seafood stem-cell freezing

Liquid-interface assisted SERS could lead to earlier detection of Alzheimer’s

OncoBone signs deals with three partners to work on bone metastases

Researchers try to bridge gap in link for patients with salmonella infection and clogged arteries

Scientists unravel mystery behind neurodegenerative disease protein

Potential new treatment for angioimmunoblastic T-cell lymphoma?

Five industrial biotech companies making Japan more sustainable

Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy

New partnership delivers clinically proven products and manufacturing processes for advanced therapies

HUTCHMED drug in colorectal cancer trial meets primary endpoint

Neurocrine to conduct placebo-controlled study to investigate potential new treatment for schizophrenia

Deciphering the molecular mechanisms of severe COVID-19

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!